[Hepatitis associated aplastic anemia during SARS-CoV-2 pandemic]. / Anemia aplásica asociada a hepatitis durante la pandemia por SARS-CoV-2.
Rev Fac Cien Med Univ Nac Cordoba
; 79(2): 201-204, 2022 06 06.
Article
in Spanish
| MEDLINE | ID: covidwho-1904163
ABSTRACT
The hepatitis-associated aplastic anemia is one of the acquired bone marrow failure syndromes. It is a stereotyped form of presentation of aplastic anemia and accounts for 2 - 5 % of the cases in the West. Its treatment, which does not differ from that of aplastic anemia, consists of immunosuppression when bone marrow transplant is not possible. Nonetheless, during the SARS-CoV-2 pandemic, recommendations restricting the use of antithymocyte globulin to those cases with the highest risk of death have been issued, since the prognosis of CoViD-19 tends to be worse if administered. We present an otherwise-healthy 18-year-old male who was diagnosed with a hepatitis-associated aplastic anemia and received a personalized treatment following these recommendations.
RESUMEN
La anemia aplásica asociada a hepatitis es uno de los síndromes de fallo medular adquirido. Es una forma estereotipada de presentación de la anemia aplásica adquirida y representa el 2 - 5 % de los casos en occidente. Su tratamiento, que no difiere del de la anemia aplásica adquirida, consiste en inmunosupresión cuando el trasplante de células progenitoras hematopoyéticas no es posible. Sin embargo, durante la pandemia por SARS-CoV-2 se han publicado recomendaciones mediante las cuales se restringe el uso de globulina antitimocítica para aquellos casos con riesgo de muerte porque el pronóstico de la CoViD-19 tiende a ser peor con su uso. Presentamos el caso de un varón de 18 años previamente sano a quien se le diagnosticó una anemia aplásica asociada a hepatitis y se le personalizó el tratamiento acorde a estas recomendaciones.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Hepatitis
/
Anemia, Aplastic
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
Spanish
Journal:
Rev Fac Cien Med Univ Nac Cordoba
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS